TAMMY KRUGER: Open Payments
NPI 1184135766 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 40 payments from 13 companies in 2025. Trend: 2023 $801 · 2024 $152 · 2025 $854
Food & beverage: $796Education: $58
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $238 |
| Lundbeck LLC | 9 | $140 |
| Dexcom, Inc. | 1 | $136 |
| Neurocrine BioSciences, Inc. | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Mannkind Corporation | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
| Boston Scientific Corporation | 1 | $29 |
| SK Life Science, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: REXULTI, AUSTEDO XR, DEXCOM G7 GSS (161), INGREZZA, AFREZZA, MOUNJARO, WATCHMAN Access System, UZEDY.
Industry payments across MI — which companies pay providers there.
